Clemastine Enhances Myelination, Delays Axonal Loss and Promotes Functional Recovery in Spinal Cord Injury.

Neurochem Res · 2022 · PMC8827101 · PMID 34661796

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.1000

boldest claim

The sentences

showed a trendp < 0.001actually significant

The clemastine-treated group showed a trend of reduced footfalls, which reached significance (p < 0.001).

also in 53,322 other papers

failed to reach significancep = 0.1so close (0.05 < p ≤ 0.1)

The clemastine-treated group showed a trend of reduced latency, which failed to reach significance (p = 0.1).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.